FDAFDA · Food and drugs·Recall number D-0139-2024
Trospium Chloride Extended-Release Capsules, 60 mg, 30 Capsules per bottle, Rx Only, Manufactured By: Sidmak Laboratories (India) Pvt. Ltd. Plot No. 20, Pharmacity, Selaqui Industrial Area, Dehradun-248 197 Uttarakhand, India Distributed By: Padagis, Allegan, MI 49010. NDC: 0574-0118-30
Published December 13, 2023 · Recall initiated: November 1, 2023
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablets/Capsules specifications; missing/broken/extra tablets within the capsules
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- TROSPIUM CHLORIDE
- Manufacturer
- Padagis US LLC
- Distributor
- Nationwide in the USA
- Lot
- Lot: 231104, 231105, 231106, exp 7/31/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.